| Year |
Citation |
Score |
| 2020 |
Sipka S, Nagy J, Sipka P, Kocsis J, Tóth J, Árkosy P, Horváth Z. Analysis of Low Cancer Mortality Rates in the Wine Regions of Tokaj and Balaton in Hungary. International Journal of Environmental Research and Public Health. 17. PMID 32948068 DOI: 10.3390/Ijerph17186759 |
0.336 |
|
| 2020 |
Mezei T, Hajdu M, Czigléczki G, Lotz G, Kocsis J, Kulka J, Horváth A. Sterile, abscess-like cerebral lesion during trastuzumab therapy after HER2 status switch in a triple negative breast cancer patient: a case report and literature review. Bmc Cancer. 20: 615. PMID 32611325 DOI: 10.1186/S12885-020-07114-7 |
0.31 |
|
| 2018 |
Gráf L, Barabás L, Madaras B, Garam N, Maláti É, Horváth L, Prohászka Z, Horváth Z, Kocsis J. High serum Hsp70 level predicts poor survival in colorectal cancer: Results obtained in an independent validation cohort. Cancer Biomarkers : Section a of Disease Markers. PMID 30452400 DOI: 10.3233/Cbm-181683 |
0.607 |
|
| 2018 |
Kocsis J, Szekanecz É, Bassam A, Uhlyarik A, Pápai Z, Rubovszky G, Mezősi E, Rucz K, Garai I, Nagy E, Uray I, Horváth Z. First Line Sorafenib Treatment for Metastatic Medullary Thyroid Cancer: Efficacy and Safety Analysis. Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association. PMID 29506310 DOI: 10.1055/S-0044-100378 |
0.339 |
|
| 2018 |
Garam N, Maláti É, Sinkovits G, Gombos T, Szederjesi A, Barabás L, Gráf L, Kocsis J, Prohászka Z. Platelet Count, ADAMTS13 Activity, von Willebrand Factor Level and Survival in Patients with Colorectal Cancer: 5-Year Follow-up Study. Thrombosis and Haemostasis. 118: 123-131. PMID 29304532 DOI: 10.1160/Th17-07-0548 |
0.686 |
|
| 2017 |
Kurzrock R, Hickish T, Wyrwicz L, André T, Sarosiek T, Kocsis J, Nemecek R, Wu Q, Mohanty P, Stecher M, Simard J, Dinarello C. Pre-treatment endogenous interleukin-1 receptor antagonist (IL-1Ra) levels in metastatic colorectal cancer (mCRC) patients are associated with clinical outcomes after anti-interleukin-1a therapy (MABp1). Annals of Oncology : Official Journal of the European Society For Medical Oncology. 28: iii98-iii99. PMID 32136086 DOI: 10.1093/Annonc/Mdx261.280 |
0.34 |
|
| 2017 |
Maráz A, Csejtei A, Kocsis J, Szűcs M, Kahán Z, Bodoky G, Dank M, Mangel L, Révész J, Varga Z, Géczi L. Assessment of the Role of Everolimus Therapy in Patients with Renal Cell Carcinoma Based on Daily Routine and Recent Research Results. Pathology Oncology Research : Por. PMID 29027615 DOI: 10.1007/S12253-017-0317-0 |
0.335 |
|
| 2017 |
Jubran R, Kocsis J, Garam N, Maláti É, Gombos T, Barabás L, Gráf L, Prohászka Z, Fishelson Z. Circulating mitochondrial Stress-70 protein/mortalin and cytosolic Hsp70 in blood: Risk indicators in colorectal cancer. International Journal of Cancer. PMID 28791678 DOI: 10.1002/Ijc.30918 |
0.701 |
|
| 2017 |
Hickish T, Andre T, Wyrwicz L, Saunders M, Sarosiek T, Kocsis J, Nemecek R, Rogowski W, Lesniewski-Kmak K, Petruzelka L, Apte RN, Mohanty P, Stecher M, Simard J, de Gramont A. MABp1 as a novel antibody treatment for advanced colorectal cancer: a randomised, double-blind, placebo-controlled, phase 3 study. The Lancet. Oncology. PMID 28094194 DOI: 10.1016/S1470-2045(17)30006-2 |
0.423 |
|
| 2016 |
Kószó R, Sántha D, Büdi L, Erfán J, Győrfy K, Horváth Z, Kocsis J, Landherr L, Hitre E, Máhr K, Pajkos G, Pápai Z, Kahán Z. Capecitabine in Combination with Docetaxel in First Line in HER2-Negative Metastatic Breast Cancer: an Observational Study. Pathology Oncology Research : Por. PMID 27771885 DOI: 10.1007/S12253-016-0129-7 |
0.334 |
|
| 2013 |
Hurvitz SA, Dirix L, Kocsis J, Bianchi GV, Lu J, Vinholes J, Guardino E, Song C, Tong B, Ng V, Chu YW, Perez EA. Phase II randomized study of trastuzumab emtansine versus trastuzumab plus docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 1157-63. PMID 23382472 DOI: 10.1200/Jco.2012.44.9694 |
0.356 |
|
| 2013 |
Rozenberg P, Kocsis J, Saar M, Prohászka Z, Füst G, Fishelson Z. Elevated levels of mitochondrial mortalin and cytosolic HSP70 in blood as risk factors in patients with colorectal cancer. International Journal of Cancer. 133: 514-8. PMID 23319326 DOI: 10.1002/Ijc.28029 |
0.634 |
|
| 2012 |
Kocsis J, Graf L, Szilagyi A, Dome B, Tamasi L, Galffy G, Orosz Z, Prohaszka Z, Fust G, Bartfai Z. The 8.1 Ancestral Haplotype is Strongly Associated with the Risk of Small Cell Lung Cancer Annals of Oncology. 23. DOI: 10.1016/S0923-7534(20)34091-6 |
0.536 |
|
| 2011 |
Kocsis J, Mészáros T, Madaras B, Tóth EK, Kamondi S, Gál P, Varga L, Prohászka Z, Füst G. High levels of acute phase proteins and soluble 70 kDa heat shock proteins are independent and additive risk factors for mortality in colorectal cancer. Cell Stress & Chaperones. 16: 49-55. PMID 20730518 DOI: 10.1007/S12192-010-0220-Z |
0.614 |
|
| 2010 |
Kocsis J, Madaras B, Tóth EK, Füst G, Prohászka Z. Serum level of soluble 70-kD heat shock protein is associated with high mortality in patients with colorectal cancer without distant metastasis. Cell Stress & Chaperones. 15: 143-51. PMID 19578980 DOI: 10.1007/S12192-009-0128-7 |
0.622 |
|
| 2009 |
Molvarec A, Derzsy Z, Kocsis J, Boze T, Nagy B, Balogh K, Makó V, Cervenak L, Mézes M, Karádi I, Prohászka Z, Rigó J. Circulating anti-heat-shock-protein antibodies in normal pregnancy and preeclampsia. Cell Stress & Chaperones. 14: 491-8. PMID 19205928 DOI: 10.1007/S12192-009-0102-4 |
0.571 |
|
| 2007 |
Tóth EK, Kocsis J, Madaras B, Bíró A, Pocsai Z, Fust G, Blaskó B, Karádi I, Adány R, Laki J. The 8.1 ancestral MHC haplotype is strongly associated with colorectal cancer risk. International Journal of Cancer. 121: 1744-8. PMID 17594690 DOI: 10.1002/Ijc.22922 |
0.394 |
|
| 2007 |
Kocsis J, Toth KE, Madaras B, Biro A, Fust G, Blasko B, Pocsai Z, Adany R, Laki J. The 8.1 ancestral MHC haplotype is strongly associatied with colorectal cancer Journal of Clinical Oncology. 25: 10548-10548. DOI: 10.1200/Jco.2007.25.18_Suppl.10548 |
0.336 |
|
| 2005 |
Papp D, Prohászka Z, Kocsis J, Füst G, Bánhegyi D, Raynes DA, Guerriero V. Development of a sensitive assay for the measurement of antibodies against heat shock protein binding protein 1 (HspBP1): increased levels of anti-HspBP1 IgG are prevalent in HIV infected subjects. Journal of Medical Virology. 76: 464-9. PMID 15977250 DOI: 10.1002/Jmv.20384 |
0.553 |
|
| 2005 |
Füst G, Beck Z, Bánhegyi D, Kocsis J, Bíró A, Prohászka Z. Antibodies against heat shock proteins and cholesterol in HIV infection. Molecular Immunology. 42: 79-85. PMID 15488946 DOI: 10.1016/J.Molimm.2004.07.003 |
0.533 |
|
| 2004 |
Quintana FJ, Buzas E, Prohászka Z, Bíró A, Kocsis J, Füst G, Falus A, Cohen IR. Knock-out of the histidine decarboxylase gene modifies the repertoire of natural autoantibodies. Journal of Autoimmunity. 22: 297-305. PMID 15120753 DOI: 10.1016/J.Jaut.2004.03.003 |
0.469 |
|
| 2003 |
Kocsis J, Prohászka Z, Bíró A, Füst G, Bánhegyi D. Elevated levels of antibodies against 70 kDa heat shock proteins in the sera of patients with HIV infection. Journal of Medical Virology. 71: 480-2. PMID 14556258 DOI: 10.1002/Jmv.10507 |
0.536 |
|
| 2002 |
Kocsis J, Veres A, Vatay A, Duba J, Karádi I, Füst G, Prohászka Z. Antibodies against the human heat shock protein hsp70 in patients with severe coronary artery disease. Immunological Investigations. 31: 219-31. PMID 12472181 DOI: 10.1081/Imm-120016242 |
0.565 |
|
| Show low-probability matches. |